Yumanity Therapeutics, Inc. YMTX
1.89 +1.89
Day range unavailable
52-week range unavailable
News
investorplace.com Why Are Chinese Stocks Up Today? Chinese stocks are rallying on Monday as investors get more hopeful news of the country loosening its Covid-19 restrictions. Over the weekend, China reportedly let go of some of its restrictions on…
investorplace.com Why Is Yumanity Therapeutics (YMTX) Stock Up Today? Yumanity Therapeutics (NASDAQ: YMTX ) stock is rocketing higher on Monday after the clinical-stage biopharmaceutical company announced a special dividend. According to a press release from the…
pennystocks.com Best Penny Stocks to Buy That Exploded Today? 3 to Watch Check these penny stocks out for your watchlist right now The post Best Penny Stocks to Buy That Exploded Today? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information |…
investorplace.com Why Is Yumanity Therapeutics (YMTX) Stock Up 50% Today? Yumanity Therapeutics (YMTX) stock is rocketing higher on Monday after announcing two definitive agreements. including a merger.
benzinga.com Yumanity Therapeutics Shares Trading Higher Today - Read Here Why Yumanity Therapeutics Inc (NASDAQ: YMTX) has agreed to sell its lead clinical-stage product candidate, YTX-7739, and discovery-stage neuroscience candidates to Janssen Pharmaceutica NV, a unit of…
zacks.com Yumanity Therapeutics (YMTX) Reports Q1 Loss, Misses Revenue Estimates Yumanity (YMTX) delivered earnings and revenue surprises of -21.57% and 31.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 671 companies achieved new lows for the year.
benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 147 companies achieved new lows for the year.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday's session saw 95 companies set new 52-week lows.
benzinga.com 52 Biggest Movers From Yesterday Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion.- benzinga.com 35 Stocks Moving In Wednesday's Mid-Day Session Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares jumped 67.1% to $26.15 after the company announced it will be acquired by UCB for approximately $1.9 billion.
benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 400 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 615 stocks hit new 52-week lows.
globenewswire.com Yumanity Therapeutics to Present at the H.C. Wainwright BioConnect Conference BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying…
globenewswire.com Yumanity Therapeutics to Present at Multiple Upcoming November Investor Conferences BOSTON, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying…
benzinga.com Yumanity Therapeutics Stock Plunges After Parkinson's Trial Data Yumanity Therapeutics Inc (NASDAQ: YMTX) reported topline data from Phase 1b trial of its lead product candidate, YTX-7739, for mild-to-moderate Parkinson's disease. The study achieved its primary…
globenewswire.com Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Oct. 14, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying…
globenewswire.com Yumanity Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) BOSTON, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying…
globenewswire.com Yumanity Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Developments YTX-7739 shown to inhibit its novel target in healthy volunteers at levels consistent with improved motor function in an animal model of Parkinson's disease
benzinga.com Stocks That Hit 52-Week Lows On Wednesday During Wednesday's morning trading, 47 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's morning session, 216 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows.
globenewswire.com Yumanity Therapeutics to Present at the 2021 B. Riley Securities' Neuroscience Conference BOSTON, April 28, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying…
globenewswire.com Yumanity Therapeutics' YTX-7739 Achieved Target Engagement at Doses That Were Generally Well Tolerated in a Phase 1a Multiple Ascending Dose Study in Healthy Volunteers YTX-7739 is Yumanity's lead product candidate in clinical development for the treatment of Parkinson's disease YTX-7739 is Yumanity's lead product candidate in clinical development for the treatment…
benzinga.com Yumanity Therapeutics' Glioblastoma Candidate Shows Efficacy In Animal Studies Yumanity Therapeutics (NASDAQ: YMTX) has announced results from preclinical studies of YTX-7739 in glioblastoma multiforme (GBM). Researchers at the Massachusetts General Hospital conducted the study.
globenewswire.com Yumanity Therapeutics Reports Full Year 2020 Financial Results and Recent Corporate Developments Closed $33.6 million PIPE in conjunction with the completion of reverse merger with Proteostasis Therapeutics; commenced trading on the Nasdaq Capital Market under the ticker symbol “YMTX”
globenewswire.com Yumanity Therapeutics to Present at the H.C. Wainwright Global Life Sciences Conference BOSTON, March 02, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying…
benzinga.com Yumanity Therapeutics Sees Lead Candidate Interim Data From Early-Stage Parkinson's Study By Mid-2021 Yumanity Therapeutics Inc (NASDAQ: YMTX) reported results from the Phase 1 single ascending dose study in 40-healthy volunteers, evaluating its lead candidate, YTX-7739, an SCD inhibitor, for the…
globenewswire.com Yumanity Therapeutics Provides Update on Its Lead Parkinson's Disease Clinical Program, YTX-7739 Results reported of the single ascending dose study in healthy volunteers
globenewswire.com Yumanity Therapeutics to Present at the H.C. Wainwright Virtual BioConnect Conference BOSTON, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying…- benzinga.com 77 Biggest Movers From Yesterday Gainers Synthetic Biologics, Inc. (NYSE: SYN) shares climbed 100% to close at $1.00 on Tuesday after gaining over 30% on Monday.
benzinga.com 84 Biggest Movers From Yesterday Gainers AeroCentury Corp. (NYSE: ACY) shares climbed 414.9% to close at $13.85 on Monday after the company reported that the NYSE accepted its plan for continued listing.- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com 58 Stocks Moving In Monday's Mid-Day Session Gainers AeroCentury Corp. (NYSE: ACY) shares jumped 227.2% to $8.80 after the company reported that the NYSE accepted its plan for continued listing.